ARTICLE
23 November 2020

The Board Of Advertisement Decision On Food Supplements

DI
Deris IP Attorneys

Contributor

Deris is a one-stop shop for IP services with one of the largest and internationally regarded IP prosecution and advisory team. We have been the pioneer in shaping the IP landscape by obtaining the precedent decisions and participating the preparation of the IP legislation upon the invitation of the legislative bodies. We provide a wide spectrum of high-quality services that are essential for securing, maintaining and enforcing IP rights.
The Board of Advertisement has decided on July 14, 2020 for suspension of the complained advertisements with regard to "No Attack" branded products and also imposed a fine of TRY 104'781.- (for each) on the advertiser as well as individuals promoting this product through social media accounts.
Turkey Media, Telecoms, IT, Entertainment

 The Board of Advertisement has decided on July 14, 2020 for suspension of the complained advertisements with regard to "No Attack" branded products and also imposed a fine of TRY 104'781.- (for each) on the advertiser as well as individuals promoting this product through social media accounts.

The Board has indicated that it is prohibited to make any kind of health declarations concerning food supplements without receiving the permissions from the relevant Regulatory Authority, i.e. Turkish Ministry of Health Pharmaceuticals and Medical Devices Agency.

The Board states that the advertising videos subject to complaint included the message that this product can be used in respect of the viral infections such as Covid-19, flu and cold and that would be helpful for treatment. Therefore, the Board has concluded that the advertisements concerning "No attack" branded products were misleading and deceptive since they were promoted as if they were pharmaceuticals and no authorization was obtained from the related Regulatory Authority.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More